SMAD2 and hepatocellular carcinoma: Indeed, Li et al.88showed that Piezo1 activation promotes hepatoma cell migration by 47% via TGF-β/Smad2/3 signaling, with an in vivo reduction in tumor volume of 38% upon Piezo1 knockdown (p < 0.01).